Open fractures
Showing 9976 - 10000 of >10,000
Burn Injury Trial in Seoul (ALLO-ASC-DFU, Conventional Therapy)
Active, not recruiting
- Burn Injury
- ALLO-ASC-DFU
- Conventional Therapy
-
Seoul, Korea, Republic ofHallym university Medical Center
Jul 19, 2021
Lifestyle, Perceived Barriers and Development of Change in
Completed
- Prostatic Neoplasm
- +3 more
-
Reggio Emilia, ItalyAzienda USL - IRCCS
Nov 10, 2021
Ventral Hernia Trial in Asheville, Charlotte, Greenville (Group 1)
Recruiting
- Ventral Hernia
- Group 1
-
Asheville, North Carolina
- +2 more
Jan 6, 2022
To Determine Brain Target Occupancy of BPN14770 Trial in New York (BPN14770, T2310)
Withdrawn
- To Determine Brain Target Occupancy of BPN14770
- BPN14770, T2310
-
New York, New YorkWeill Cornell Medicine
Dec 16, 2021
Solid Tumor, Adult Trial in United States (GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose)
Recruiting
- Solid Tumor, Adult
- GAd-209-FSP low dose
- +5 more
-
Duarte, California
- +12 more
Oct 2, 2022
Solid Tumors and Hematologic Malignancy Trial in Belgium, Netherlands, United States (INCB059872, all-trans retinoic acid
Terminated
- Solid Tumors and Hematologic Malignancy
- INCB059872
- +3 more
-
Birmingham, Alabama
- +14 more
Jun 29, 2022
Collect Clinical Data to Document Clinical Performance and
Recruiting
- Total Knee Arthroplasty
- +3 more
- patient with knee arthroplasty
-
Lyon, FranceHopital de la Croix-Rousse, Hospices Civils de Lyon
Jul 28, 2022
Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )
Recruiting
- Hematological Disease
- Allogeneic Hematopoietic Stem Cell Transplantation
- Hetrombopag
- placebo
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023
Mortality and Complications After Lung Surgery, Open Thoracic
Recruiting
- Morality
- +3 more
- Lung surgery
- +3 more
-
Bangkoknoi, Bangkok, ThailandAnesthesiology Department Siriraj Hospital
Oct 23, 2021
Hyperbilirubinemia, Neonatal Trial in Nanjing
Recruiting
- Hyperbilirubinemia, Neonatal
-
Nanjing, Jiangsu, ChinaNanjing Maternity and Child Health Care Hospital
Oct 29, 2021
HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)
Completed
- HIV
- Burkitt's Lymphoma
- Induction Phase
- +4 more
-
Aviano (PN), Italy
- +7 more
Aug 2, 2022
ARDS Trial in Chicago, Akron, Cleveland (MultiStem, Placebo)
Recruiting
- ARDS
- MultiStem
- Placebo
-
Chicago, Illinois
- +3 more
Sep 7, 2021
Breast Cancer Trial in Philadelphia (Abemaciclib, Hydroxychloroquine)
Recruiting
- Breast Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 13, 2021
Migraine, Head Pain Trial in Valladolid (Candesartan)
Recruiting
- Migraine
- Head Pain
-
Valladolid, SpainHospital Clínico Universitario Valladolid
Feb 9, 2022
Esophageal Squamous Cell Carcinoma (ESCC) Trial in Taiwan (BI-754091 plus afatinib)
Enrolling by invitation
- Esophageal Squamous Cell Carcinoma (ESCC)
- BI-754091 plus afatinib
-
Kaohsiung, Taiwan
- +4 more
Aug 30, 2021
Advanced Solid Tumor, Colorectal Cancer, Lung Cancer Trial in Randwick (KF-0210 tablets, 120 mg, KF-0210 tablets, 240 mg,
Recruiting
- Advanced Solid Tumor
- +5 more
- KF-0210 tablets, 120 mg
- +6 more
-
Randwick, New South Wales, AustraliaScientia Clinical Research Limited
Aug 31, 2021
Common Wart, Warts Hand, Warts Trial in United States (VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin,
Completed
- Common Wart
- +11 more
- VP-102 Cantharidin topical film forming solution
- VP-102 Cantharidin, topical film forming solution
-
Little Rock, Arkansas
- +4 more
Aug 5, 2021
Lung Sarcomatoid Carcinoma Trial in Beijing, Shanghai (Savolitinib)
Active, not recruiting
- Lung Sarcomatoid Carcinoma
-
Beijing, Beijing, China
- +1 more
Nov 29, 2021
Idiopathic Pulmonary Fibrosis (IPF) Trial in Shanghai (ZSP1603, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- ZSP1603
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Lung Hospital
Nov 3, 2021
Hypertension Trial in Beijing (SPH3127 200mg Panel A, SPH3127 200mg Panel B)
Completed
- Hypertension
- SPH3127 200mg Panel A
- SPH3127 200mg Panel B
-
Beijing, Beijing, ChinaThe capital medical university affiliated Beijing anzhen hospita
Nov 11, 2021
Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)
Recruiting
- Hepatocellular Carcinoma
-
Hong Kong, Hong KongDepartment of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022